Summary
The present review was written to describe the effects of the COVID-19 pandemic on followup and
treatment process of gynecological cancers and breast cancer in accordance with current literature,
guidelines from national and international cancer associations. Recommendations were provided based
on the consensus conference model. In the follow-up and treatment process of gynecological cancers
and breast cancer, there are many factors, such as the clinical course of patient, the possibility of an
emergency of the patient, the stage of the cancer and the current status of the chemotherapies. Although
opinions in all types of cancer differ among themselves, general beliefs are postponement of non-urgent
surgical operations, re-evaluation of chemotherapy processes, postponing appointments for new nonurgent
diagnoses, reducing the length of hospital stay of patients in emergency procedures, conducting
consultations by telemedicine or telephone, treatment of patients with COVID-19 suspicions after 15
days, planning biopsies or surgeries according to the staging status of cancers and planning conferences
as video conferences in cases that require a multidisciplinary approach. Patients diagnosed with cancer
during the COVID-19 pandemic should not be lost, followup and treatment should be continued without
disruption, patients should be remembered to be in the high-risk group in this process and necessary
hygiene measures should be taken in both follow-up and treatment concerning risks and COVID-19
pandemics.
